About: ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013 Goto Sponge NotDistinct Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

Attributes	Values
rdf:type	skos:Concept http://linked.opendata.cz/ontology/domain/vavai/Vysledek
rdfs:seeAlso	http://onlinelibrary.wiley.com/doi/10.1111/1469-0691.12371/pdf
Description	These European Society for Clinical Microbiology and Infectious Diseases and European Confederation of Medical Mycology Joint Clinical Guidelines focus on the diagnosis and management of mucormycosis. Only a few of the numerous recommendations can be summarized here. To diagnose mucormycosis, direct microscopy preferably using optical brighteners, histopathology and culture are strongly recommended. Pathogen identification to species level by molecular methods and susceptibility testing are strongly recommended to establish epidemiological knowledge. The recommendation for guiding treatment based on MICs is supported only marginally. Imaging is strongly recommended to determine the extent of disease. To differentiate mucormycosis from aspergillosis in haematological malignancy and stem cell transplantation recipients, identification of the reverse halo sign on computed tomography is advised with moderate strength. These European Society for Clinical Microbiology and Infectious Diseases and European Confederation of Medical Mycology Joint Clinical Guidelines focus on the diagnosis and management of mucormycosis. Only a few of the numerous recommendations can be summarized here. To diagnose mucormycosis, direct microscopy preferably using optical brighteners, histopathology and culture are strongly recommended. Pathogen identification to species level by molecular methods and susceptibility testing are strongly recommended to establish epidemiological knowledge. The recommendation for guiding treatment based on MICs is supported only marginally. Imaging is strongly recommended to determine the extent of disease. To differentiate mucormycosis from aspergillosis in haematological malignancy and stem cell transplantation recipients, identification of the reverse halo sign on computed tomography is advised with moderate strength. (en)
Title	ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013 ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013 (en)
skos:prefLabel	ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013 ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013 (en)
skos:notation	RIV/00216224:14740/14:00076471!RIV15-MSM-14740___
http://linked.open...avai/riv/aktivita	I
http://linked.open...avai/riv/aktivity	I
http://linked.open...iv/cisloPeriodika	April
http://linked.open...vai/riv/dodaniDat	2015
http://linked.open...aciTvurceVysledku	Freiberger, Tomáš
http://linked.open.../riv/druhVysledku	J - Článek v odborném periodiku
http://linked.open...iv/duvernostUdaju	S - Úplné a pravdivé údaje nepodléhající ochraně podle zvláštních právních předpisů
http://linked.open...titaPredkladatele	Masarykova univerzita / Středoevropský technologický institut
http://linked.open...dnocenehoVysledku	14978
http://linked.open...ai/riv/idVysledku	RIV/00216224:14740/14:00076471
http://linked.open...riv/jazykVysledku	eng - angličtina
http://linked.open.../riv/klicovaSlova	LIPOSOMAL AMPHOTERICIN-B; INVASIVE FUNGAL-INFECTIONS; ORBITAL-CEREBRAL MUCORMYCOSIS; IN-VITRO SUSCEPTIBILITIES; FRAGMENT LENGTH POLYMORPHISM; HEMATOLOGY-ONCOLOGY PATIENTS; ORGAN TRANSPLANT RECIPIENTS; DESORPTION IONIZATION-TIME (en)
http://linked.open.../riv/klicoveSlovo	FRAGMENT LENGTH POLYMORPHISM HEMATOLOGY-ONCOLOGY PATIENTS IN-VITRO SUSCEPTIBILITIES INVASIVE FUNGAL-INFECTIONS LIPOSOMAL AMPHOTERICIN-B ORBITAL-CEREBRAL MUCORMYCOSIS ORGAN TRANSPLANT RECIPIENTS DESORPTION IONIZATION-TIME
http://linked.open...odStatuVydavatele	US - Spojené státy americké
http://linked.open...ontrolniKodProRIV	[135AB34AF34D]
http://linked.open...i/riv/nazevZdroje	Clinical Microbiology and Infection
http://linked.open...in/vavai/riv/obor	EE
http://linked.open...ichTvurcuVysledku	1 (xsd:int)
http://linked.open...cetTvurcuVysledku	34 (xsd:int)
http://linked.open...UplatneniVysledku	2014
http://linked.open...v/svazekPeriodika	20
http://linked.open...iv/tvurceVysledku	Freiberger, Tomáš Lagrou, K. Pagano, L. Skiada, A. Boekhout, T. Richardson, M. Akova, M. Arendrup, M. C. Arikan- Akdagli, S. Chakrabarti, A. Chowdhary, A. Cornely, O. A. Cuenca- Estrella, M. Dannaoui, E. Groll, A. H. Guarro, J. Guinea, J. Hope, W. Johnson, E. Kathuria, S. Lackner, M. Lanternier, F. Lass- Flörl, C. Lortholary, O. Meis, J. F. Melatiadis, J. Munoz, P. Petrikkos, G. Roilides, E. Tortorano, A. M. Ullmann, A. J. Verweij, P. de Hoog, S. van Diepeningen, A.
http://linked.open...ain/vavai/riv/wos	000332445700002
issn	1198-743X
number of pages	22 (xsd:int)
http://bibframe.org/vocab/doi	10.1111/1469-0691.12371
http://localhost/t...ganizacniJednotka	14740

Faceted Search & Find service v1.16.118 as of Jun 21 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 48 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software